Regulation of PD-L1(CD274) expression
Zhou YJ, Li G, Wang J, Liu M, Wang Z, Song Y, Zhang X, Wang X. PD-L1: expression regulation. Blood Sci. 2023 Apr;5(2):77–91. PMID: 37228770; PMCID: PMC10205351.; Yamaguchi H, Hsu JM, Yang WH, Hung MC. Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics. Nat Rev Clin Oncol. 2022 May;19(5):287–305. doi: 10.1038/s41571-022-00601-9. PMID: 35132224.; Ju X, Zhang H, Zhou Z, Wang Q. Regulation of PD-L1 expression in cancer and clinical implications in immunotherapy. Am J Cancer Res. 2020;10(1):1–11. PMID: 32064150; PMCID: PMC7017746.; Cha JH, Chan LC, Li CW, Hsu JL, Hung MC. Mechanisms Controlling PD-L1 Expression in Cancer. Mol Cell. 2019 Nov 07;76(3):359–70. PMID: 31668929; PMCID: PMC6981282.; Sharpe AH, Pauken KE. The diverse functions of the PD1 inhibitory pathway. Nat Rev Immunol. 2018 Mar;18(3):153–67. doi: 10.1038/nri.2017.108. PMID: 28990585.; Arasanz H, Gato-Cañas M, Zuazo M, Ibañez-Vea M, Breckpot K, Kochan G, Escors D. PD1 signal transduction pathways in T cells. Oncotarget. 2017 Aug 01;8(31):51936–45. PMID: 28881701; PMCID: PMC5584302.; Chen J, Jiang CC, Jin L, Zhang XD. Regulation of PD-L1: a novel role of pro-survival signalling in cancer. Ann Oncol. 2016 Mar;27(3):409–16. doi: 10.1093/annonc/mdv615. PMID: 26681673.; Riley JL. PD-1 signaling in primary T cells. Immunological Reviews. 2009 Apr 21;229(1):114–25. doi: 10.1111/j.1600-065x.2009.00767.x.